• Find an Expert
  • Contact
  • SearchSearch icon
  • Menu
  • Help
  • Report an issue

Contact


Email

steven.tong@unimelb.edu.au

Credentials


Position
Clinical Professorial Fellow
Department of Infectious Diseases
Education
PhD
Charles Darwin Univeristy
Bachelors Degree (Honours)
University of Melbourne
ORCID

0000-0002-1368-8356

Prof Steven Tong

Clinical Professorial Fellow
Department of Infectious Diseases

485 Scholarly works
48 Projects

HIGHLIGHTS

  • 2026

    Journal article

    Perspectives of Information Access in the Informed Consent Process for Clinical Research Participation in Australia
    DOI: 10.1002/eahr.70011
  • 2026

    Journal article

    Effect of in vitro synergy and additivity of vancomycin or daptomycin plus an antistaphylococcal β-lactam for methicillin-resistant Staphylococcus aureus bacteraemia on mortality: preplanned analysis from CAMERA2
    DOI: 10.1016/j.cmi.2026.01.032
  • 2026

    Journal article

    Incidence and clinical implication of trimethoprim/sulfamethoxazole susceptibility discrepancy between VITEK-2 and disc diffusion testing methods in Central Australia
    DOI: 10.1016/j.cmi.2025.12.019
  • 2026

    Journal article

    Hierarchical composite endpoints provide a flexible framework to ensure clinical trials measure outcomes important to all stakeholders.
    DOI: 10.1093/cid/ciag277
  • 2025

    Research grants (ARC, NHMRC, MRFF)

    The Staphylococcus Aureus Network Adaptive Platform (SNAP) Trial
  • 2025

    Research grants (ARC, NHMRC, MRFF)

    Promoat: An Adaptive Platform Trial of Antibiotic Therapy to Improve Outcomes From Preterm Prelabour Rupture of Membranes
  • 2020

    Research grants (ARC, NHMRC, MRFF)

    The Staphylococcus Aureus Network Adaptive Platform Trial
Steven Tong

Latest Honours,
Awards and Fellowships


2006
Fellow of the Royal Australasian College of Physicians (FRACP)

RECENT SCHOLARLY WORKS

  • 2026

    Journal article

    Evidence Over Eminence: Rethinking Specialty Guidelines Amid the ATS-IDSA Debate.
    DOI: 10.1093/cid/ciag267
  • 2026

    Journal article

    Association between β-lactam exposure and clearance of bacteraemia and acute kidney injury in patients with methicillin-resistant Staphylococcus aureus bloodstream infections-a post hoc analysis of the CAMERA2 trial.
    DOI: 10.1016/j.cmi.2026.04.006
  • 2026

    Journal article

    2025 Update to WikiGuidelines for the management of pyogenic osteomyelitis in adults
    DOI: 10.1016/j.amjmed.2025.10.040
  • 2026

    Journal article

    Patient-reported Perceptions, Experiences, and Preferences Around Intravenous and Oral Antibiotics for the Treatment of Staphylococcus aureus Bacteremia: A Descriptive Qualitative Study
    DOI: 10.1093/cid/ciaf522
  • 2026

    Journal article

    The CLARITY initiative: Clinical Literature Appraisal and Research education in InfecTious diseases and microbiologY
    DOI: 10.1016/j.cmicom.2025.105155
  • 2026

    Journal article

    Comparing different methods for analysing hierarchical composite endpoints: two illustrative case studies with post hoc analyses of the BALANCE (Bacteraemia Antibiotic Length Actually Needed for Clinical Effectiveness) and CAMERA2 (Combination Antibiotics for methicillin-resistant Staphylococcus aureus) randomized clinical trials
    DOI: 10.1016/j.cmi.2025.11.027

RECENT PROJECTS

  • 2025

    Research grants (ARC, NHMRC, MRFF)

    STReptococcal Adaptive Platform Trial (STRAP)
  • 2024

    Research grants (ARC, NHMRC, MRFF)

    Laboratory Detection and Clinical Significance of the Cefazolin Inoculum Effect for Staphylococcus Aureus Bloodstream Infections

We acknowledge and pay respect to the Traditional Owners of the lands upon which our campuses are situated

Read about our commitment to reconciliation  

About us  

Careers at Melbourne  

Safety and respect  

Newsroom  

Contact  

Phone: 13 MELB ( 13 6352)

International: +61 3 9035 5511


Address:
The University of Melbourne
Grattan Street, Parkville,
Victoria, 3010, Australia


View all Campus locations  
facebookIconlinkedinIconinstagramIcontwitterIcon

Emergency information  |  Disclaimer and copyright  |  Accessibility  |  Privacy  |  VaxFACTS

CRICOS number: 00116K     ABN: 84 002 705 224